Lunit Inc.
Case number(s)
Decision date
DecisionConsent granted
Section 13(1)(a) of the Overseas Investment Act 2005
Decision makerToitū Te Whenua Land Information New Zealand
Decision date30 January 2024
Pathway(s)Significant business assets
InvestmentAcquisition of up to 100% of the shares in Volpara Health Technologies Limited
ApplicantLunit Inc.
South Korea (86%)
United States of America (10%)
Japan (2%)
Various (2%)
VendorHealth Technologies Limited
New Zealand (100%)

The Applicant develops and manufactures artificial intelligence enabled cancer and disease detection software and devices used at over 2,000 sites globally. The Applicant seeks consent to acquire 100% of the Vendor’s shares under a scheme of arrangement pursuant to Part 15 of the Companies Act 1993.

The Vendor develops software and imaging products for early detection of breast and lung cancer.

Consent was granted as the Applicant met the investor test criterion.

More informationAnnie Steel
Harmos Horton Lusk Limited
Level 33, Vero Centre
48 Shortland Street
Auckland 1010